Expression of miR-34a is a sensitive biomarker for exposure to genotoxic agents in human lymphoblastoid TK6 cells

Mutat Res Genet Toxicol Environ Mutagen. 2020 Aug-Sep:856-857:503232. doi: 10.1016/j.mrgentox.2020.503232. Epub 2020 Jul 15.

Abstract

miR-34a has been identified as a tumor suppressor microRNA (miRNA) involved in the P53 network. Its expression levels correlate to carcinogenesis, which are generally lower in tumor tissue and higher in response to DNA damage. In this study, the response of miR-34a from exposure to genotoxic agents in human lymphoblastoid TK6 cells was evaluated to assess whether the expression of this miRNA could be used as an early indicator for genotoxic damage in mammalian cells. TK6 cells were treated with seven genotoxic agents with different mode-of-actions (cisplatin, N-ethyl-N-nitrosourea, etoposide, mitomycin C, methyl methanesulphonate, taxol, and X-ray radiation) and a non-genetic toxin (usnic acid) at different concentrations for four hours (except for X-rays) and the expression levels of miR-34a were measured 24 h after the beginning of the treatments. The expression levels of miR-34a were significantly increased by these genetic toxins in a dose-dependent manner, while no significant change in miRNA expression was found in the usnic acid-treated cells. These results suggest that miR-34a can respond to genotoxic insults sensitively; thus, miR-34a expression has the potential to be used to evaluate genotoxicity of agents.

Keywords: Biomarker; Genotoxicity; Mutagen; miR-34a; miRNA expression.

MeSH terms

  • Apoptosis / drug effects
  • Biomarkers / metabolism
  • Carcinogenesis / drug effects
  • Carcinogenesis / genetics*
  • Cisplatin / pharmacology
  • Cisplatin / toxicity
  • DNA Damage / drug effects*
  • Ethylnitrosourea / pharmacology
  • Etoposide / pharmacology
  • Etoposide / toxicity
  • Gene Expression Regulation / drug effects*
  • Genes, Tumor Suppressor
  • Humans
  • MicroRNAs / genetics*
  • Mutagens / pharmacology
  • Mutagens / toxicity

Substances

  • Biomarkers
  • MIRN34 microRNA, human
  • MicroRNAs
  • Mutagens
  • Etoposide
  • Ethylnitrosourea
  • Cisplatin